Vincents Bjarne, Onnerfjord Patrik, Gruca Milosz, Potempa Jan, Abrahamson Magnus
Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Lund University, University Hospital, S-221 85 Lund, Sweden.
Biol Chem. 2007 Apr;388(4):437-46. doi: 10.1515/BC.2007.042.
Of seven human cystatins investigated, none inhibited the cysteine proteases staphopain A and B secreted by the human pathogen Staphylococcus aureus. Rather, the extracellular cystatins C, D and E/M were hydrolyzed by both staphopains. Based on MALDI-TOF time-course experiments, staphopain A cleavage of cystatin C and D should be physiologically relevant and occur upon S. aureus infection. Staphopain A hydrolyzed the Gly11 bond of cystatin C and the Ala10 bond of cystatin D with similar Km values of approximately 33 and 32 microM, respectively. Such N-terminal truncation of cystatin C caused >300-fold lower inhibition of papain, cathepsin B, L and K, whereas the cathepsin H activity was compromised by a factor of ca. 10. Similarly, truncation of cystatin D caused alleviated inhibition of all endogenous target enzymes investigated. The normal activity of the cystatins is thus down-regulated, indicating that the bacterial enzymes can cause disturbance of the host protease-inhibitor balance. To illustrate the in vivo consequences, a mixed cystatin C assay showed release of cathepsin B activity in the presence of staphopain A. Results presented for the specificity of staphopains when interacting with cystatins as natural protein substrates could aid in the development of therapeutic agents directed toward these proteolytic virulence factors.
在研究的7种人半胱氨酸蛋白酶抑制剂中,没有一种能抑制人类病原体金黄色葡萄球菌分泌的半胱氨酸蛋白酶葡萄球菌蛋白酶A和B。相反,细胞外半胱氨酸蛋白酶抑制剂C、D和E/M被这两种葡萄球菌蛋白酶水解。基于基质辅助激光解吸电离飞行时间(MALDI-TOF)时间进程实验,葡萄球菌蛋白酶A对半胱氨酸蛋白酶抑制剂C和D的切割在生理上应该是相关的,并且在金黄色葡萄球菌感染时发生。葡萄球菌蛋白酶A水解半胱氨酸蛋白酶抑制剂C的Gly11键和半胱氨酸蛋白酶抑制剂D的Ala10键,其米氏常数(Km)值相似,分别约为33和32微摩尔。半胱氨酸蛋白酶抑制剂C的这种N端截短导致对木瓜蛋白酶、组织蛋白酶B、L和K的抑制作用降低300倍以上,而组织蛋白酶H的活性受到约10倍的影响。同样,半胱氨酸蛋白酶抑制剂D的截短导致对所有研究的内源性靶酶的抑制作用减轻。因此,半胱氨酸蛋白酶抑制剂的正常活性被下调,这表明细菌酶可导致宿主蛋白酶-抑制剂平衡的紊乱。为了说明体内后果,一项混合半胱氨酸蛋白酶抑制剂C测定显示在存在葡萄球菌蛋白酶A的情况下组织蛋白酶B活性的释放。所呈现的关于葡萄球菌蛋白酶与作为天然蛋白质底物的半胱氨酸蛋白酶抑制剂相互作用的特异性结果,可能有助于开发针对这些蛋白水解毒力因子的治疗剂。